Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

5.7K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-driven neoantigen identification: a comprehensive review from somatic variant calling to T cell recognition.

Journal of translational medicine·2026
Same author

Designing a novel therapeutic candidate vaccine for HPV16 using immunoinformatics approach: Targeting E6 and E7 epitopes with TLR4 agonist integration.

BioImpacts : BI·2026
Same author

Comparative molecular dynamics mapping of metallocarboxypeptidase-peptide interfaces reveals potential hotspots that inspire novel inhibitor design.

Scientific reports·2026
Same author

A structural bioinformatics framework for prioritizing pH-sensitive proteins from 3D structural features.

BMC bioinformatics·2026
Same author

In Vivo Tracking Modalities for Oncolytic Reovirus: Principles, Clinical Applications, and Translational Integration.

Molecular imaging and biology·2026
Same author

Conopeptides as Modulators of Pain and Inflammation in Chemotherapy-Induced Peripheral Neuropathy by Targeting α7 and α9 Nicotinic Acetylcholine Receptors.

Neurotoxicity research·2026
Same journal

Engineering a synthetic niche for hADSC preconditioning with PRP, Lp-SN, and resveratrol nanoparticles.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

<i>In-vitro</i> mineralization of borosilicate glasses and accompanying evolution of porous architecture.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Antibacterial and antibiofilm evaluation of biogenic ternary CuO-AgO-MgO nanocomposite against clinical isolates of carbapenem-resistant <i>Klebsiella pneumoniae</i>.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Real-time RNA sensors for diabetes management: assessing the impact of endocrine disruptors on biosensing and point-of-care diagnostics.

Artificial cells, nanomedicine, and biotechnology·2026
Same journal

Folate receptor-targeted PEGylated PLGA nanoparticles for the site-specific delivery of hesperidin in epithelial ovarian cancer.

Artificial cells, nanomedicine, and biotechnology·2026
See all related articles

Related Experiment Video

Updated: Feb 27, 2026

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

7.5K

Lung regeneration using amniotic fluid mesenchymal stem cells.

Alireza Azargoon1, Babak Negahdari2

  • 1a Department of Internal Medicine , Lorestan University of Medical Sciences , Khoramabad , Iran.

Artificial Cells, Nanomedicine, and Biotechnology
|July 5, 2017
PubMed
Summary
This summary is machine-generated.

Amniotic fluid mesenchymal stem cells (AFMSCs) offer a promising solution for lung regeneration and addressing organ shortages in transplantation. Their accessibility and differentiation potential make them ideal for tissue engineering and regenerative medicine applications.

Keywords:
Re-cellularizationamniotic fluid mesenchymal stem cellslungregeneration

More Related Videos

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.8K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.9K

Related Experiment Videos

Last Updated: Feb 27, 2026

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System
08:24

The Production of Pluripotent Stem Cells from Mouse Amniotic Fluid Cells Using a Transposon System

Published on: February 28, 2017

7.5K
Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats
09:31

Evaluation of Stem Cell Therapies in a Bilateral Patellar Tendon Injury Model in Rats

Published on: March 30, 2018

11.8K
Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.9K

Area of Science:

  • Regenerative Medicine
  • Tissue Engineering
  • Pulmonary Medicine

Background:

  • Respiratory diseases cause irreversible lung damage, posing significant global health challenges.
  • Lung transplantation is the primary treatment but faces limitations including graft rejection, cancer, and short survival rates (~5 years).
  • A critical shortage of donor lungs necessitates innovative solutions for organ availability.

Purpose of the Study:

  • To review the potential of amniotic fluid mesenchymal stem cells (AFMSCs) for lung tissue regeneration.
  • To highlight AFMSCs as a viable cell source for lung scaffold re-cellularization.
  • To emphasize the role of AFMSCs in advancing tissue engineering and regenerative medicine for pulmonary applications.

Main Methods:

  • Literature review on the application of AFMSCs in regenerative medicine.
  • Analysis of AFMSC properties relevant to lung tissue engineering.
  • Evaluation of AFMSCs for scaffold re-cellularization strategies.

Main Results:

  • AFMSCs demonstrate limitless accessibility and significant potential for proliferation and differentiation.
  • These properties make AFMSCs an optimal cell source for re-cellularizing lung scaffolds.
  • AFMSCs present a promising alternative to overcome limitations in current lung transplantation strategies.

Conclusions:

  • AFMSCs represent a highly promising cell source for lung regeneration.
  • Further research in tissue engineering and regenerative medicine should focus on utilizing AFMSCs.
  • Developing AFMSC-based therapies can potentially increase the availability of suitable organs for transplantation and improve patient outcomes.